Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2017 Jun 1;75(Suppl 2):S149–S155. doi: 10.1097/QAI.0000000000001368

Table 3. Adjusted and Unadjusted Logistic Regression showing factors associated with Virologic Suppression at 6 months.

Characteristic Unadjusted OR (95% CI) Adjusted OR (95% CI)

Study Arm
Arm 1 (Referent) 1.0 1.0
Arm 2 0.81 (0.45- 1.40) 0.76 (0.43-1.30)
Arm 3 1.13 (0.61 - 2.12) 1.17 (0.65-2.10)

Age
<25 (Referent) 1.0 1.0
>= 25 0.91 (0.63-1.33) 1.01 (0.68-1.49)

WHO stage
Stage 1 (Referent) 1.0 1.0
Stage 2, 3 or 4 1.87 (0.82-4.27) 2.01 (0.84-4.81)

Pregnancy status
Pregnant (Ref) 1.0 1.0
Lactating 0.83 (0.49-1.40) 0.71 (0.41-1.22)

Default Event
Yes (Referent) 1.0 1.0
No 0.25 (0.15-0.42) 0.23 (0.14-0.38)

Refers to status at the time of enrolment into the study, not at the time of HIVRNA collection.